Jacobi Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Jacobi Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,100	Closed	-$38K	–	1335
2020 Q2	$38K	Hold	2,100	–	–	0.01%	525
2020 Q1	$15K	Hold	2,100	–	–	﹤0.01%	641
2019 Q4	$50K	Hold	2,100	–	–	0.01%	474
2019 Q3	$56K	Hold	2,100	–	–	0.01%	437
2019 Q2	$57K	Hold	2,100	–	–	0.01%	429
2019 Q1	$73K	Hold	2,100	–	–	0.02%	353
2018 Q4	$41K	Hold	2,100	–	–	0.01%	418
2018 Q3	$56K	Hold	2,100	–	–	0.02%	404
2018 Q2	$79K	Hold	2,100	–	–	0.02%	355
2018 Q1	$65K	Hold	2,100	–	–	0.02%	352
2017 Q4	$101K	Hold	2,100	–	–	0.03%	260
2017 Q3	$115K	Hold	2,100	–	–	0.04%	224
2017 Q2	$125K	Buy	+2,100	New	+$84.1K	0.05%	174

Jacobi Capital Management's PTLA Position: Q3 2020 in Review

Jacobi Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 2,100 shares — an estimated $38K sold.

Jacobi Capital Management first reported a position in PTLA in Q2 2017 and held it in 13 quarters. The position peaked at $125K in Q2 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Jacobi Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Jacobi Capital Management sold 2,100 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $38K.
Jacobi Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2017 and held it in 13 quarters.
Jacobi Capital Management's Portola Pharmaceuticals, Inc. position peaked at $125K in Q2 2017.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Jacobi Capital Management's 13F filing for Q3 2020, filed 30 Oct 2020.